Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.53 |
| ▸ | POLB | P06746 | 2/20 | 0.53 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | APEX1 | P27695 | 1/20 | 0.53 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | HTT | P42858 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | EGFR | P00533 | 1/20 | 0.47 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9266213 | 0.94 | TDP1 (0.49) | GAAPOLBTDP1APEX1CTBP2 | |
| SCHEMBL9269526 | 0.88 | POLB (0.56) | GAAPOLBTDP1APEX1SMN1; SMN2 | |
| SCHEMBL8403545 | 0.87 | POLB (0.61) | GAAPOLBLMNAHTTKMT2A | |
| SCHEMBL11253749 | 0.84 | GAA (0.57) | GAASMN1; SMN2LMNAKDM4EKMT2A | |
| SCHEMBL2208662 | 0.83 | GAA (0.52) | GAAPOLBTDP1APEX1CTBP2 | |
| SCHEMBL28138970 | 0.81 | KMT2A (0.47) | GAACTBP2SMN1; SMN2LMNAKDM4E | |
| SCHEMBL1515223 | 0.80 | CTBP2 (0.56) | GAAPOLBTDP1APEX1CTBP2 | |
| SCHEMBL1620786 | 0.80 | TDP1 (0.47) | GAAPOLBTDP1APEX1CTBP2 | |
| SCHEMBL10775630 | 0.80 | POLB (0.55) | POLBTDP1KDM4EKMT2AHSD17B10 | |
| SCHEMBL526194 | 0.80 | GAA (0.57) | GAAPOLBTDP1APEX1CTBP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 747 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119684105-A | N-phenyl isatin-mediated ketone-carboxylic acid conversion reaction method | 贵州医科大学 | 2025-03-25 | — | — | CN | claimed |
| CN-119552838-A | Amine dehydrogenase catalytic system, application thereof and eutectic solvent and preparation thereof | 河北工业大学 | 2025-03-04 | — | — | CN | claimed |
| CN-118201991-A | Methods and compositions for reducing solvent release from agrochemical formulations and reducing agrochemical formulation odor | 安道麦马克西姆有限公司 | 2024-06-14 | — | — | CN | claimed |
| EP-3315579-B1 | SURFACE TREATMENT AGENT INCLUDING PERFLUORO(POLY)ETHER GROUP-CONTAINING SILANE COMPOUND | DAIKIN IND LTD (JP) | 2024-05-01 | — | — | EP | claimed |
| CN-114950159-B | Preparation method of aromatic polymer separation membrane based on super acid catalysis | 南京工业大学 | 2023-06-06 | — | — | CN | claimed |
| CN-114950159-A | Preparation method of aromatic polymer separation membrane based on super-acid catalysis preparation | 南京工业大学 | 2022-08-30 | — | — | CN | claimed |
| CN-113663463-B | Odor inhibitor | 日东生物科技(浙江)有限公司 | 2022-08-02 | — | — | CN | claimed |
| CN-114574455-A | Method for forming supramolecular hydrogel for biocatalysis by utilizing enzyme self-assembly | 清华大学 | 2022-06-03 | — | — | CN | claimed |
| EP-3088487-B1 | SURFACE TREATING AGENT INCLUDING PERFLUORO(POLY)ETHER-GROUP-CONTAINING SILANE COMPOUND | DAIKIN IND LTD (JP) | 2021-05-05 | — | — | EP | claimed |
| CN-112374974-A | Method for synthesizing isomagnoflorine | 郑州大学 | 2021-02-19 | — | — | CN | claimed |
| US-20160340544-A1 | SURFACE TREATING AGENT INCLUDING PERFLUORO(POLY)ETHER-GROUP-CONTAINING SILANE COMPOUND | DAIKIN INDUSTRIES, LTD. (JP) | 2016-11-24 | — | — | US | claimed |
| EP-3088487-A1 | SURFACE TREATING AGENT INCLUDING PERFLUORO(POLY)ETHER-GROUP-CONTAINING SILANE COMPOUND | Daikin Industries, Ltd. (JP) | 2016-11-02 | — | — | EP | claimed |
| CN-105849222-A | Surface treating agent comprising perfluoro (poly) ether group-containing silane compound | 大金工业株式会社 | 2016-08-10 | — | — | CN | claimed |
| CN-104710256-A | Cheap and efficient synthesis method of alpha-hydroxyketone compound | UNIV BEIJING | 2015-06-17 | — | — | CN | claimed |
| CN-101891569-B | Preparation method of alpha-aromatic ketone compound | UNIV WUHAN | 2013-07-24 | — | — | CN | claimed |
| CN-102311457-A | Preparation method of rosuvastatin | SUZHOU LAKESTAR PHARMATECH CO LTD | 2012-01-11 | — | — | CN | claimed |
| EP-1670314-A4 | METHODS AND COMPOSITIONS COMPRISING DIAMINES AS NEW ANTI-TUBERCULAR THERAPEUTICS | SEQUELLA INC (US) | 2009-02-25 | — | — | EP | claimed |
| EP-1670314-A2 | METHODS AND COMPOSITIONS COMPRISING DIAMINES AS NEW ANTI-TUBERCULAR THERAPEUTICS | Sequella, Inc. (US) | 2006-06-21 | — | — | EP | claimed |
| US-20050113574-A1 | Methods and compositions comprising diamines as new anti-tubercular therapeutics | SEQUELLA, INC. | 2005-05-26 | — | — | US | claimed |
| WO-2005034857-A2 | METHODS AND COMPOSITIONS COMPRISING DIAMINES AS NEW ANTI-TUBERCULAR THERAPEUTICS | SEQUELLA, INC. (US) | 2005-04-21 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050113574-A1 | Methods and compositions comprising diamines as new anti-tubercular therapeutics | C5, DDC, SAT1 | GAA 466/4885POLB 101/4885TDP1 716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.